GSK Japan Sales Grow 22 Percent In 2009
This article was originally published in PharmAsia News
Despite 2 percent growth in GlaxoSmithKline's global pharmaceutical sales in 2009, sales in Japan grew 22 percent, according to the annual results announced Feb. 4
You may also be interested in...
Suppliers to the UK’s National Health Service from outside the EU could save up to 12% during COVID-19 emergency measures as the UK tries to increase supplies
Coronavirus Update: Neurimmune, Ethris, Fujifilm, Brii In New Bids Against COVID-19, Reata, Ionis Delay Studies
Neurimmune and Ethris partner on inhaled therapy. Reata, Ionis and others delay trials, Brii announces China antibody alliance, Fujifilm starts favipiravir trials. World's largest trial for health workers starts.
China insurance giant snatches up stakes in Japanese pharma and a traditional Chinese medicines maker with a $465m spending spree.